CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

University of Siena - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/education

education organization

University of Siena

IT

OPENALEX: I102064193↗ROR: 01tevnk56↗

People

Connected researchers

Alfonso TrezzaORCID 0000-0002-3304-1066 Andrea FagioliniExact authorship link Annalisa SantucciORCID 0000-0001-6976-9086 Anna VisibelliORCID 0000-0001-9281-034X Behnaz ShababExact authorship link Bianca RoncagliaORCID 0009-0002-0009-4011 Collins Nyaberi Nyong’aExact authorship link Elisabetta MiraldiORCID 0000-0002-2130-8624 Fabrizio ManettiORCID 0000-0002-9598-2339 Filomena RussoORCID 0000-0003-2780-7720 Giada TroviniORCID 0000-0001-8711-5326 Giorgio CappellucciORCID 0009-0001-2037-3133 Giovanni IsoldiExact authorship link Luana PeruzziORCID 0000-0003-4924-5423 Luisa FruscianteORCID 0000-0002-4031-3066 Marco BiagiORCID 0000-0003-2997-4178 Michela GeminianiORCID 0000-0002-6910-0056 Ottavia SpigaORCID 0000-0002-0263-7107 Paolo GovernaORCID 0000-0002-5976-780X Pierfrancesco MastroeniORCID 0009-0001-5369-3950 Rebecca FinettiORCID 0009-0000-6969-1493 Roberta BarlettaORCID 0009-0002-2750-7082 Roberto BerniORCID 0000-0002-6101-9042 Stefania LamponiORCID 0000-0002-2788-8797 Tommaso OlmastroniORCID 0009-0002-7445-6935 Vittoria BorgonettiORCID 0000-0002-2203-5285

Public evidence

10 connected articles

Partial Dopamine D2/3 Agonists and Dual Disorders: A Retrospective-Cohort Study in a Real-World Clinical Setting on Patients with Schizophrenia Spectrum Disorders and Cannabis Use Disorder.2025 · Europe PMC Enhancing Industrial Hemp (<i>Cannabis sativa</i>) Leaf By-Products: Bioactive Compounds, Anti-Inflammatory Properties, and Potential Health Applications.2025 · Europe PMC A Stroll Through Saffron Fields, Cannabis Leaves, and Cherry Reveals the Path to Waste-Derived Antimicrobial Bioproducts.2025 · Europe PMC Predicting therapy dropout in chronic pain management: a machine learning approach to cannabis treatment.2025 · Europe PMC Extraction, purification and <i>in vitro</i> assessment of the antioxidant and anti-inflammatory activity of policosanols from non-psychoactive <i>Cannabis sativa</i> L.2024 · Europe PMC Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling.2022 · Europe PMC The Pharmacogenetics of Cannabis in the Treatment of Chronic Pain.2022 · PubMed Central Open Access Cannabidiol Isolated From <i>Cannabis sativa</i> L. Protects Intestinal Barrier From <i>In Vitro</i> Inflammation and Oxidative Stress.2021 · PubMed Central Open Access Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study.2019 · PubMed Central Open Access Impact of Nitrogen Nutrition on <i>Cannabis sativa</i>: An Update on the Current Knowledge and Future Prospects.

Matched by exact identifiers only. Profile data: OpenAlex.

2019 · PubMed Central Open Access